title: Colorectal cancer: Overcoming resistance to anti-EGFR therapy - where do we stand?
authors.affiliation: Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Los Angeles, California 90033, USA.
authors.forename: Marta
authors.initials: M
authors.lastname: Schirripa
authors.affiliation: Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Los Angeles, California 90033, USA.
authors.forename: Heinz-Josef
authors.initials: HJ
authors.lastname: Lenz
mesh_terms: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D015179:Colorectal Neoplasms; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D066246:ErbB Receptors / Q000235:genetics; D006801:Humans; D009154:Mutation / Q000187:drug effects*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D066246:ErbB Receptors